| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.
|
Gastroenterology
|
1999
|
5.79
|
|
2
|
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.
|
Lancet
|
1995
|
4.71
|
|
3
|
Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.
|
J Virol
|
2001
|
4.48
|
|
4
|
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained.
|
Eur J Immunol
|
2000
|
3.36
|
|
5
|
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.
|
J Infect Dis
|
2000
|
2.98
|
|
6
|
Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.
|
J Exp Med
|
1991
|
2.38
|
|
7
|
[21-year-old patient with recurrent diarrhea, weight loss, leg edema and iron deficiency. Gluten sensitive sprue].
|
Internist (Berl)
|
2002
|
2.04
|
|
8
|
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.
|
J Virol
|
1997
|
1.98
|
|
9
|
Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
|
Hepatology
|
1995
|
1.72
|
|
10
|
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
|
J Virol
|
1995
|
1.71
|
|
11
|
Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
|
J Hepatol
|
1998
|
1.67
|
|
12
|
Differential antigen-processing pathways of the hepatitis B virus e and core proteins.
|
Gastroenterology
|
1999
|
1.52
|
|
13
|
Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
|
J Immunol
|
1999
|
1.46
|
|
14
|
Precore mutant hepatitis B virus infection and liver disease.
|
Gastroenterology
|
1992
|
1.31
|
|
15
|
Purification, fractionation and assay of antibody-dependent lymphocytic effector cells (K cells) in human blood.
|
Scand J Immunol
|
1976
|
1.27
|
|
16
|
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases.
|
Gastroenterology
|
1983
|
1.26
|
|
17
|
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.
|
Hepatology
|
1992
|
1.19
|
|
18
|
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B.
|
Clin Exp Immunol
|
1998
|
1.19
|
|
19
|
Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy.
|
Virology
|
1992
|
1.15
|
|
20
|
The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.
|
J Mol Med (Berl)
|
1996
|
1.14
|
|
21
|
Hepatitis after chronic abuse of senna.
|
Lancet
|
1991
|
1.13
|
|
22
|
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.
|
Cell Immunol
|
2000
|
1.12
|
|
23
|
Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area.
|
Virology
|
1991
|
1.10
|
|
24
|
Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
|
J Virol
|
2005
|
1.09
|
|
25
|
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
|
Hepatology
|
2000
|
1.09
|
|
26
|
Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.
|
Virology
|
1999
|
1.08
|
|
27
|
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
|
Hepatology
|
2000
|
1.05
|
|
28
|
Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.
|
J Viral Hepat
|
2006
|
1.00
|
|
29
|
Natural cytotoxicity of human Fc gamma-receptor-positive T lymphocytes after surface modulation with immune complexes.
|
Scand J Immunol
|
1979
|
1.00
|
|
30
|
A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha.
|
Dig Dis Sci
|
1995
|
0.98
|
|
31
|
Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.
|
J Immunol
|
1977
|
0.97
|
|
32
|
[Pathological anatomy of Waterhouse-Friderichsen syndrome with special reference to disseminated intravascular coagulation].
|
Dtsch Med Wochenschr
|
1973
|
0.95
|
|
33
|
Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. I. Surface markers and K cell activity after separation of B cells and lymphocytes and Fc-receptors by column fractionation.
|
J Immunol
|
1977
|
0.94
|
|
34
|
Simultaneous occurrence of immunoglobulin-dependent and immunoglobulin-independent mechanisms in natural cytotoxicity of human lymphocytes.
|
J Immunol
|
1979
|
0.94
|
|
35
|
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro.
|
J Virol
|
1996
|
0.94
|
|
36
|
Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.
|
Hepatology
|
1988
|
0.93
|
|
37
|
Mapping of B-cell epitopes of the human hepatitis B virus X protein.
|
J Virol
|
1990
|
0.93
|
|
38
|
Chronic diarrhea as a result of intestinal microsposidiosis in a liver transplant recipient.
|
Transplantation
|
2001
|
0.91
|
|
39
|
Immunogenicity of human hepatitis B virus P-gene derived proteins.
|
J Immunol
|
1989
|
0.88
|
|
40
|
Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
|
Int J Cancer
|
1980
|
0.84
|
|
41
|
Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication.
|
J Virol
|
1990
|
0.84
|
|
42
|
Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
|
Liver Transpl
|
2000
|
0.83
|
|
43
|
Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation.
|
Transpl Int
|
1995
|
0.83
|
|
44
|
Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection.
|
J Med Virol
|
1985
|
0.81
|
|
45
|
Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clones.
|
J Virol
|
2001
|
0.81
|
|
46
|
Interferon alpha in hepatitis type B and non-A, non-B. Defective production by peripheral blood mononuclear cells in chronic infection and development of serum interferon in acute disease.
|
J Hepatol
|
1988
|
0.81
|
|
47
|
Influence of HLA alleles on outcome of hepatitis C virus infection.
|
Lancet
|
2000
|
0.81
|
|
48
|
T cell recognition of hepatitis B and C viral antigens.
|
Eur J Clin Invest
|
1994
|
0.81
|
|
49
|
Heterogeneity and mechanism of action of human natural killer lymphocytes: differential distribution of receptors for Helix pomatia haemagglutinin (HP receptors).
|
Scand J Immunol
|
1979
|
0.80
|
|
50
|
Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
|
J Infect Dis
|
2001
|
0.79
|
|
51
|
Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions.
|
Clin Exp Immunol
|
1997
|
0.79
|
|
52
|
High prevalence and heterogeneity of HBV preC mutants in anti-HBe-positive carriers with chronic liver disease in southern Italy.
|
J Hepatol
|
1991
|
0.79
|
|
53
|
Cytolytic T cell clones derived from liver tissue of patients with chronic hepatitis B.
|
Eur J Immunol
|
1986
|
0.79
|
|
54
|
Cell-mediated immune reactions to human tumors.
|
Cancer
|
1977
|
0.78
|
|
55
|
Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.
|
Z Gastroenterol
|
1999
|
0.78
|
|
56
|
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C.
|
Digestion
|
2000
|
0.78
|
|
57
|
Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis.
|
Clin Exp Immunol
|
1989
|
0.78
|
|
58
|
Immunopathogenesis of HCV infection.
|
Curr Stud Hematol Blood Transfus
|
1998
|
0.77
|
|
59
|
Allelic variation in the TNF-beta gene does not explain the low TNF-beta response in patients with primary biliary cirrhosis.
|
Scand J Immunol
|
1991
|
0.77
|
|
60
|
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.
|
Liver
|
2000
|
0.77
|
|
61
|
Determination of Hepatitis C Virus-Specific CD4(+) T-Cell Activity in PBMC.
|
Methods Mol Med
|
1999
|
0.77
|
|
62
|
The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors.
|
J Immunol
|
1977
|
0.77
|
|
63
|
[Liver transplantation in hemophilia A?].
|
Internist (Berl)
|
1995
|
0.77
|
|
64
|
[Hairy cell leukaemia. I. Clinical features, cytochemistry, phagocytosis, establishment of permanent growing cell lines (author's transl)].
|
Dtsch Med Wochenschr
|
1976
|
0.76
|
|
65
|
[Scleredema adultorum Buschke and primary biliary cirrhosis in a 58-year-old patient].
|
Internist (Berl)
|
1984
|
0.75
|
|
66
|
Role for CD4 positive T cell response in the pathogenesis of hepatitis B.
|
J Hepatol
|
1997
|
0.75
|
|
67
|
HLA and hepatitis B infection.
|
Lancet
|
1995
|
0.75
|
|
68
|
Selection for a pre-C stop codon mutation in a hepatitis B virus variant with a pre-C initiation codon mutation during interferon treatment.
|
J Hepatol
|
1991
|
0.75
|
|
69
|
[Quincke edema as a manifestation of food allergy].
|
Internist (Berl)
|
1987
|
0.75
|
|
70
|
[Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
|
Fortschr Med
|
1988
|
0.75
|
|
71
|
[46-year-old patient with congenital actinic dermatosis and progressive liver failure after travel to Southeast Asia].
|
Internist (Berl)
|
1991
|
0.75
|
|
72
|
[Life-threatening intestinal hemorrhage in a 21-year-old high performance athlete].
|
Internist (Berl)
|
1989
|
0.75
|
|
73
|
[59-year-old patient with cutaneous lesions and increased iron metabolism parameters].
|
Internist (Berl)
|
2000
|
0.75
|
|
74
|
Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
|
J Clin Lab Anal
|
1994
|
0.75
|
|
75
|
[Experimental studies on proteolysis of hyaline membranes in vitro (author's transl)].
|
Klin Wochenschr
|
1975
|
0.75
|
|
76
|
[A 61-year-old patient with a 15-month history of progressive diffuse abdominal pains].
|
Internist (Berl)
|
1988
|
0.75
|
|
77
|
[Chronic increased cholestasis parameters and sonographic echogenic round liver lesions in a clinically healthy male].
|
Internist (Berl)
|
1989
|
0.75
|
|
78
|
Interferon-alpha-induced agranulocytosis in a patient on long-term clozapine therapy.
|
J Hepatol
|
1998
|
0.75
|
|
79
|
[23-year-old patient with abdominal pain, hepatosplenomegaly, ascites and leg edema].
|
Internist (Berl)
|
1995
|
0.75
|
|
80
|
[Hepatic coma of unknown origin in an 18-year-old patient].
|
Internist (Berl)
|
1991
|
0.75
|
|
81
|
[Role of IgG-dependent K(killer) cells of peripheral blood in a tumor system].
|
Verh Dtsch Ges Inn Med
|
1978
|
0.75
|
|
82
|
Natural killer cell activity during treatment with fibroblast interferon.
|
Immunobiology
|
1981
|
0.75
|
|
83
|
[Proceedings: Fibrinolysis studies on pulmonary hyaline membranes in vitro].
|
Verh Dtsch Ges Pathol
|
1974
|
0.75
|
|
84
|
[Right-sided epigastric pain and ascites in a 24-year-old female patient].
|
Internist (Berl)
|
1993
|
0.75
|
|
85
|
Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity.
|
Arch Virol Suppl
|
1993
|
0.75
|
|
86
|
[54-year-old patient with severe dyspnea 6 months after the implantation of a peritoneovenous shunt].
|
Internist (Berl)
|
1985
|
0.75
|
|
87
|
[A 65-year old jaundiced patient with weight loss, fever and sicca syndrome].
|
Internist (Berl)
|
1990
|
0.75
|
|
88
|
[The NK (natural killer) cell in human peripheral blood].
|
Verh Dtsch Ges Inn Med
|
1978
|
0.75
|
|
89
|
[A 27-year old patient with watery diarrhea, nausea and vomiting 10 hours after eating a mushroom dish. Interdisciplinary liver transplantation team of the Grosshadern Clinic].
|
Internist (Berl)
|
1994
|
0.75
|
|
90
|
Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
|
Natl Cancer Inst Monogr
|
1978
|
0.75
|
|
91
|
Liver transplantation in primary biliary cirrhosis: risk assessment and 11-year follow-up.
|
Digestion
|
2000
|
0.75
|